Profile
Adam Schayowitz is currently Director at Terremoto Biosciences, Inc. and will be Executive VP, Head-Research & Development at Zymeworks, Inc. starting in 2026.
Formerly, Dr. Schayowitz was Director-Business Development at BioMarker Strategies LLC in 2012.
Education includes undergraduate studies at Hamilton College (New York), a doctorate from the University of Maryland conferred in 2008, and an MBA from The Johns Hopkins University.
Adam Schayowitz active positions
| Companies | Position | Start |
|---|---|---|
| ZYMEWORKS INC. | Chief Tech/Sci/R&D Officer | 09/04/2026 |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Director/Board Member | - |
Former positions of Adam Schayowitz
| Companies | Position | End |
|---|---|---|
BioMarker Strategies LLC
BioMarker Strategies LLC Pharmaceuticals: GenericHealth Technology Develops medicines for cancer | Corporate Officer/Principal | 01/11/2012 |
Training of Adam Schayowitz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
BioMarker Strategies LLC
BioMarker Strategies LLC Pharmaceuticals: GenericHealth Technology Develops medicines for cancer | Health Technology |
Hamilton College (New York)
Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Zymeworks, Inc.
Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Adam Schayowitz
















